A phase II study of pemetrexed, carboplatin and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small cell lung cancer: CALGB 30407—Early evaluation of feasibility and toxicity

Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2015.02.014 ◽

2015 ◽

Vol 88 (2) ◽

pp. 160-166 ◽

Cited By ~ 7

Author(s):

Pilar Garrido ◽

Walburga Engel-Riedel ◽

Monika Serke ◽

Philippe Giraud ◽

Umberto Ricardi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Final overall survival (OS) results from a phase II study of pemetrexed (Pem) and cisplatin (Cis) with concurrent thoracic radiation (RT) after Pem-Cis induction in patients with unresectable locally advanced (LA) nonsquamous non-small cell lung cancer (NS-NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7539 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7539-7539

Author(s):

Silvia Novello ◽

Walburga Engel-Riedel ◽

Monika Serke ◽

Philippe Giraud ◽

Carla Visseren-Grul ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non–small-cell lung cancer

Journal of Radiation Research ◽

10.1093/jrr/rrv062 ◽

2015 ◽

Vol 57 (1) ◽

pp. 50-54 ◽

Cited By ~ 6

Author(s):

Takaaki Hasegawa ◽

Yohei Futamura ◽

Akane Horiba ◽

Tsutomu Yoshida ◽

Toshitaka Suzuki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

O-263 Randomized 3-arm phase II study of paclitaxel (T), carboplatin (C), and thoracic radiation (TRT) for patients with stage III non-small cell lung cancer (NSCLC). Report of locally advanced multimodality protocol (LAMP) - ACR 427

Lung Cancer ◽

10.1016/s0169-5002(03)91921-0 ◽

2003 ◽

Vol 41 ◽

pp. S77 ◽

Cited By ~ 7

Author(s):

Phil Bonomi ◽

Walter Curran ◽

Hak Choy ◽

Charles Scott ◽

Patrick Travis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

A Phase II Study of Sorafenlb In Patients with Locally Advanced And/or Metastatic (stage 1MB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation

European Journal of Cancer ◽

10.1016/s0959-8049(11)70126-5 ◽

2011 ◽

Vol 47 ◽

pp. 14 ◽

Cited By ~ 1

Author(s):

A.M. Dinqemans ◽

W.W. Mellema ◽

H.J.M. Groen ◽

A. van Wijk ◽

S. Burgers ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Ras Mutation

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90818-4 ◽

2003 ◽

Vol 1 (5) ◽

pp. S238 ◽

Cited By ~ 1

Author(s):

F. Cappuzzo ◽

S. Novello ◽

F. De Marinis ◽

M. Maur ◽

G. Scagliotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Nsclc Patients

Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(96)85960-5 ◽

1996 ◽

Vol 14 (1) ◽

pp. 176-177

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Preliminary Analysis ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

A phase II study of vindesine and cisplatin (VP) used concurrently with Thoracic Radiotherapy (TRT) for locally advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer ◽

10.1016/0169-5002(91)91937-7 ◽

1991 ◽

Vol 7 ◽

pp. 157

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb

Lung Cancer ◽

10.1016/j.lungcan.2011.08.006 ◽

2012 ◽

Vol 75 (3) ◽

pp. 348-352 ◽

Cited By ~ 5

Author(s):

J.R. Fischer ◽

F. Griesinger ◽

T. Fink ◽

T. Salm ◽

A. Marseille ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Durvalumab with Concurrent Definitive Radiation Therapy (DART) for Locally-Advanced Non-Small Cell Lung Cancer - A Phase II Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.584 ◽

2020 ◽

Vol 108 (3) ◽

pp. e929

Author(s):

A. Rimner ◽

M. Offin ◽

N. Shaverdian ◽

D. McKnight ◽

H. Li ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽